New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population
- PMID: 21129219
- PMCID: PMC3016329
- DOI: 10.1186/1475-2840-9-84
New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population
Abstract
Background: To investigate whether the known diabetes mellitus (KDM) or newly diagnosed diabetes mellitus (NDM) could be regarded as a coronary heart disease (CHD) risk equivalent among a relatively young Middle East population with high prevalence of diabetes mellitus (DM).
Methods: A population based cohort study of 2267 men and 2931 women, aged ≥ 30 years. Prior CHD was defined as self-reported or ECG positive CHD at baseline, KDM as subjects using any kind of glucose-lowering medications and NDM according to fasting plasma glucose and 2-h postchallenge glycemia.Participants were categorized to six groups according to the presence of known or newly diagnosed DM and CHD at baseline (DM-/CHD-, DM-/CHD+, NDM+/CHD-, NDM+/CHD+, KDM+/CHD-, KDM+/CHD+) and Cox regression analysis were used to estimate the hazard ratio (HR) of CHD events for these DM/CHD groups, given DM-/CHD-as the reference.
Results: During 7.6-year follow up, 358 CHD events occurred. After controlling traditional risk factors, HRs of CHD events for DM-/CHD+ group were 2.1 (95% CI: 1.4-3.1) and 5.2 (3.2-8.3) in men and women respectively. Corresponding HRs for NDM+/CHD-were 1.7 (1.1-2.7) and 3.1 (1.8-5.6) and for KDM+/CHD-were 1.7 (0.9-3.3) and 6.2 (3.6-10.6) in men and women respectively. The HRs for NDM+/CHD+ and KDM+/CHD+ groups (i.e. participants with history of both diabetes and CHD) were 6.4 (3.2-12.9) and 8.0 (4.3-14.8) in women and 3.2 (1.9-5.6) and 4.2 (2.2-7.8) in men, respectively.The hazard of CHD events did not differ between KDM+/CHD-and DM-/CHD+ in both genders using paired homogeneity test, however the HR for NDM+/CHD-was marginally lower than the HR for DM-/CHD+ in women (p = 0.085).
Conclusions: KDM patients in both genders and NDM especially in men exhibited a CHD risk comparable to nondiabetics with a prior CHD, furthermore diabetic subjects with prior CHD had the worst prognosis, by far more harmful in women than men; reinforcing the urgent need for intensive care and prophylactic treatment for cardiovascular diseases.
Figures
Similar articles
-
Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.BMC Public Health. 2020 Oct 6;20(1):1510. doi: 10.1186/s12889-020-09595-4. BMC Public Health. 2020. PMID: 33023566 Free PMC article.
-
Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population.Eur J Prev Cardiol. 2012 Dec;19(6):1227-33. doi: 10.1177/1741826711428065. Epub 2011 Oct 19. Eur J Prev Cardiol. 2012. PMID: 22013153
-
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.J Am Heart Assoc. 2017 Jun 6;6(6):e005344. doi: 10.1161/JAHA.116.005344. J Am Heart Assoc. 2017. PMID: 28588089 Free PMC article.
-
[Is diabetes mellitus a coronary heart disease equivalent? Results of a meta-analysis of prospective studies].Rev Esp Cardiol. 2007 Nov;60(11):1167-76. Rev Esp Cardiol. 2007. PMID: 17996177 Spanish.
-
Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women?J Womens Health (Larchmt). 2013 Nov;22(11):966-77. doi: 10.1089/jwh.2012.4087. Epub 2013 Sep 28. J Womens Health (Larchmt). 2013. PMID: 24073782 Free PMC article. Review.
Cited by
-
Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases.Antioxidants (Basel). 2022 Jun 27;11(7):1273. doi: 10.3390/antiox11071273. Antioxidants (Basel). 2022. PMID: 35883764 Free PMC article. Review.
-
External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes identified in the national diabetes program in Iran.J Diabetes Metab Disord. 2023 May 25;22(2):1145-1150. doi: 10.1007/s40200-023-01224-2. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37975087 Free PMC article.
-
Sex-specific differential in risk of diabetes-related macrovascular outcomes.Curr Diab Rep. 2015 Nov;15(11):85. doi: 10.1007/s11892-015-0662-x. Curr Diab Rep. 2015. PMID: 26370696 Free PMC article. Review.
-
Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Rev Diabet Stud. 2013 Summer-Fall;10(2-3):88-100. doi: 10.1900/RDS.2013.10.88. Epub 2013 Aug 10. Rev Diabet Stud. 2013. PMID: 24380085 Free PMC article. Review.
-
A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels.Cardiovasc Diabetol. 2011 Jun 24;10:56. doi: 10.1186/1475-2840-10-56. Cardiovasc Diabetol. 2011. PMID: 21702911 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical